References
- Ruggeri ZM. Platelet adhesion under flow. Microcirculation 2009;16(1):58–83. doi:https://doi.org/10.1080/10739680802651477.
- Gralnick HR, Rick ME, McKeown LP, Williams SB, Parker RI, Maisonneuve P, Jenneau C, Sultan Y. Platelet von Willebrand factor: an important determinant of the bleeding time in type I von Willebrand’s disease. Blood 1986;68(1):58–61. doi:https://doi.org/10.1182/blood.V68.1.58.58.
- von Nishino M. Willebrand disease: diagnosis and treatment. In: Tanaka K, Davie EW, Ikeda Y, Iwanaga S, Saito H, Sueishi K, editors. Recent advances in thrombosis and hemostasis 2008. Tokyo: Springer Japan; 2008. p. 406–423.
- Casonato A, Cattini MG, Daidone V, Pontara E, Bertomoro A, Prandoni P. Diagnostic value of measuring platelet Von Willebrand factor in von Willebrand disease. PLoS One 2016;11(8):e0161310. doi:https://doi.org/10.1371/journal.pone.0161310.
- Kanaji S, Fahs SA, Shi Q, Haberichter SL, Montgomery RR. Contribution of platelet vs. endothelial VWF to platelet adhesion and hemostasis. J Thromb Haemost 2012;10(8):1646–1652. doi:https://doi.org/10.1111/j.1538-7836.2012.04797.x.
- Maguire PB, Wynne KJ, Harney DF, O’Donoghue NM, Stephens G, Fitzgerald DJ. Identification of the phosphotyrosine proteome from thrombin activated platelets. Proteomics 2002;2(6):642–648. doi:https://doi.org/10.1002/1615-9861(200206)2:6<642::AID-PROT642>3.0.CO;2-I.
- McGrath RT, van den Biggelaar M, Byrne B, O’Sullivan JM, Rawley O, O’Kennedy R, Voorberg J, Preston RJS, O’Donnell JS. Altered glycosylation of platelet-derived von Willebrand factor confers resistance to ADAMTS13 proteolysis. Blood 2013;122(25):4107–4110. doi:https://doi.org/10.1182/blood-2013-04-496851.
- Gralnick HR, Williams SB, McKeown LP, Krizek DM, Shafer BC, Rick ME. Platelet von Willebrand factor: comparison with plasma von Willebrand factor. Thromb Res 1985;38(6):623–633. doi:https://doi.org/10.1016/0049-3848(85)90205-1.
- Cazenave J-P, Ohlmann P, Cassel D, Eckly A, Hechler B, Gachet C. Preparation of washed platelet suspensions from human and rodent blood. In: Gibbins JM, Mahaut-Smith MP, editors. Platelets and megakaryocytes. Switzerland: Humana Press; 2004. p. 13–28. ( Walker JM, editor Methods in molecular biology. vol. 272).
- deRomeuf C, Mazurier C. Interest of a simple and fast method for platelet von Willebrand factor characterization. Thromb Res 1996;83(4):287–298. doi:https://doi.org/10.1016/0049-3848(96)00137-5.
- Lavin M, Aguila S, Schneppenheim S, Dalton N, Jones KL, O’Sullivan JM, O’Connell NM, Ryan K, White B, Byrne M, et al. Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels. Blood 2017;130(21):2344–2353. doi:https://doi.org/10.1182/blood-2017-05-786699.
- Kragh T, Napoleone M, Fallah MA, Gritsch H, Schneider MF, Reininger AJ. High shear dependent von Willebrand factor self-assembly fostered by platelet interaction and controlled by ADAMTS13. Thromb Res 2014;133(6):1079–1087. doi:https://doi.org/10.1016/j.thromres.2014.03.024.
- HEPES-buffered Tyrode’s solution. Cold Spring Harb Protoc 2007;2007(2):pdb.rec10805. doi:https://doi.org/10.1101/pdb.rec10805
- Pekrul I, Kragh T, Turecek PL, Novack AR, Ott HW, Spannagl M. Sensitive and specific assessment of recombinant von Willebrand factor in platelet function analyzer. Platelets 2019;30(2):264–270. doi:https://doi.org/10.1080/09537104.2017.1420153.
- Bodó I, Eikenboom J, Montgomery R, Patzke J, Schneppenheim R, Di Paola J, von Willebrand factor Subcommittee of the Standardization and Scientific Committee of the International Society for Thrombosis and Haemostasis. Platelet-dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH. J Thromb Haemost 2015;13(7):1345–1350. doi:https://doi.org/10.1111/jth.12964.
- Takekawa H. Automated apparatus for photometrically detecting immunological agglutinating reactions. United States Patent US 4,457,893; 1984 Jul 03.
- van den Besselaar AM, Neuteboom J, Bertina RM. Effect of synthetic phospholipids on the response of the activated partial thromboplastin time to heparin. Blood Coagul Fibrinolysis 1993;4(6):895–903. doi:https://doi.org/10.1097/00001721-199312000-00006.
- Ott HW, Griesmacher A, Schnapka-Koepf M, Golderer G, Sieberer A, Spannagl M, Scheibe B, Perkhofer S, Will K, Budde U, et al. Analysis of von Willebrand factor multimers by simultaneous high- and low-resolution vertical SDS-agarose gel electrophoresis and Cy5-labeled antibody high-sensitivity fluorescence detection. Am J Clini Pathol 2010;133(2):322–330. doi:https://doi.org/10.1309/AJCPZSBTD2BWOMVL.
- Fernandez MFL, Ginsberg MH, Ruggeri ZM, Batlle FJ, Zimmerman TS. Multimeric structure of platelet Factor-VIII von Willebrand-factor - the presence of larger multimers and their reassociation with thrombin-stimulated platelets. Blood 1982;60(5):1132–1138. doi:https://doi.org/10.1182/blood.V60.5.1132.1132.
- Streiner DL. Being inconsistent about consistency: when coefficient alpha does and doesn’t matter. J Pers Assess 2003;80(3):217–222. doi:https://doi.org/10.1207/S15327752JPA8003_01.
- Affeld K, Goubergrits L, Kertzscher U, Gadischke J, Reininger A. Mathematical model of platelet deposition under flow conditions. Int J Artif Organs 2004;27(8):699–708. doi:https://doi.org/10.1177/039139880402700808.
- Affeld K, Reininger AJ, Gadischke J, Grunert K, Schmidt S, Thiele F. Fluid mechanics of the stagnation point flow chamber and its platelet deposition. Artif Organs 1995;19(7):597–602. doi:https://doi.org/10.1111/j.1525-1594.1995.tb02387.x.
- Mannucci PM. Platelet von Willebrand factor in inherited and acquired bleeding disorders. Proc Natl Acad Sci U S A 1995;92(7):2428–2432. doi:https://doi.org/10.1073/pnas.92.7.2428.
- Nachman RL, Jaffe EA. Subcellular platelet factor-VIII aantigen and von Willebrand factor. J Exp Med 1975;141(5):1101–1113. doi:https://doi.org/10.1084/jem.141.5.1101.
- Howard MA, Montgomery DC, Hardisty RM. Factor-VIII-related antigen in platelets. Thromb Res 1974;4(5):617–624. doi:https://doi.org/10.1016/0049-3848(74)90218-7.
- Daniel M, Lebreton A, Sinegre T. C N. Monitoring recombinant and plasma-derived VWF concentrates: an in vitro study. Poster presented at: ISTH 2020 virtual congress; 2020 Jul 12–14.
- McGrath RT, McKinnon TAJ, Byrne B, O’Kennedy R, Terraube V, McRae E, Preston RJS, Laffan MA, O’Donnell JS.Expression of terminal alpha 2-6-linked sialic acid on von Willebrand factor specifically enhances proteolysis by ADAMTS13. Blood 2010;115(13):2666–2673. doi:https://doi.org/10.1182/blood-2009-09-241547.
- Williams SB, McKeown LP, Krutzsch H, Hansmann K, Gralnick HR. Purification and characterization of human platelet von-Willebrand-factor. Br J Haematol 1994;88(3):582–591. doi:https://doi.org/10.1111/j.1365-2141.1994.tb05077.x.